The high prevalence and cost of untreated and inadequately controlled hypertension significantly impact microeconomics and macroeconomics, requiring long-term investment to prolong quality years of life.
The economic aspects of hypertension are critical to modern medicine. The medical, economic, and human costs of untreated and inadequately controlled hypertension are enormous. Hypertension is distributed unequally and with iniquity in different countries and regions of the world. Treatment of hypertension requires an investment over many years to prolong disease-free quality years of life. The high prevalence and high cost of the disease impacts on the microeconomics and macroeconomics of countries and regions. The criteria used for inclusion in clinical guidelines for hypertension impact on the cost and cost/utility of diagnosis or treatment.
Alcocer et al. (Sun,) conducted a review in Hypertension. The high prevalence and cost of untreated and inadequately controlled hypertension significantly impact microeconomics and macroeconomics, requiring long-term investment to prolong quality years of life.